When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
STML - Stemline rockets 151% premarket on Menarini bid
Stemline Therapeutics Inc.
Privately held Menarini Group has agreed to acquire Stemline Therapeutics (NASDAQ:STML) for $12.50 per share, consisting of $11.50 in cash plus one contingent value right (CVR) that will pay $1.00 in cash upon the completion of the first sale of Elzonris (tagraxofusp) in any EU5 country (UK, France, Spain, Germany, Italy) after European Commission approval.
More news on: Stemline Therapeutics, Inc., Healthcare stocks news, Merger & acquisition news, Stocks on the move,